Abstract:In 2005, two reports, one on analysis of 5′-RACE PCR products of p53 transcripts in human normal tissues [1] and the other on analysis of a zebrafish genetic mutant defhi429 [2], described the discovery of p53 isoforms. Since then it has raised tremendous interest in the cancer research community to unravel the function and regulation of these isoforms due to the fact that p53 (TP53) is the most important tumor suppressor. During last ten years, main focus has been put on studying one unique type of p53 isoforms, namely the zebrafish ∆113p53 and its human counterpart ∆133p53, both are transcribed by an alternative p53 promoter in intron 4 and encodes N-terminal truncated forms of p53 [3]. In summary, these studies demonstrated that ∆113p53/∆133p53 are p53 target genes and function to antagonize p53's apoptotic function or to inhibit cell replicative senescence [1, 3, 4, 5]. Recently, four zebrafish p53 isoforms, namely TA2/3/4/5p53 were identified. These isoforms are derived from a naturally occurring 4 bp genomic deletion in the intron 1 of the s113p53 gene (part of the intron 4 of the p53 gene) [6]. All of these new isoforms also promote embryo survival by repressing apoptosis upon γ-irradiation [6]. DNA double strand breaks (DSB) are the most deleterious DNA lesions that a cell can encounter. To combat these detrimental insults, three pathways have evolved for the repair of DSB: Homologous Recombination (HR), Non-Homologous End Joining (NHEJ) and Single-Strand Annealing (SSA). It is well established that full-length p53 represses DNA DSB repair by either preventing repair complex formation through interacting with several essential HR-related proteins such as RAD51 and RPA, or transcriptionally suppressing the expression of DNA DSB repair genes e.g. RAD51, RECQ4 and WRN [7]. This is consistent with the observation that p53 protein is rapidly accumulated to a high level in response to DNA DSB stress at early stage. However, activated p53 also activates the expression of MDM2, an E3 ligase that mediates the degradation of p53 at the later stage. Therefore, it is of great interest to understand the role of the activated p53 signal pathway in response to DNA DSB stress at the later stage. We showed previously that, in response to DNA damage, ∆113p53/∆133p53 is strongly induced to antagonizes p53 apoptotic activity specifically [3]. We asked whether p53 isoforms are involved in the DNA DSB repair. Our study, recently published in Cell Research, demonstrates that in response to DNA DSB stress, s113p53/s133p53 not only inhibits apoptosis, but also minimizes genetic insults by promoting all three DNA DSB repair pathways: HR, NHEJ and SSA, independently of p53 [8]. Firstly, we found that upon γ-irradiation, the accumulation of s113p53/s133p53 protein was different from that of full-length p53. p53 peaked as early as 4 hours post irradiation (hpi) and gradually decreased. s113p53/s133p53 protein reached its highest level at 24 hpi, at the same time p53 decreased to its basal level. Interestingly, induction of apoptosis was correlated positively with the level of p53 and negatively with the level of s113p53, whereas DNA damage repair was corresponding to the highest level of s113p53. Then, using artificial reporter systems, we revealed that s113p53/s133p53 promotes all three DNA DSB repair pathways in a p53-independent manner. In vivo analysis showed that the knockdown of s113p53/s133p53 reduces DNA DSB repair foci formation and increases DNA damage extents after γ-irradiation. The high level of DNA damage results cell growth arrest at G2 phase which finally leads to cell senescence at the later stage. The significance of s113p53 induction upon γ-irradiation was further demonstrated in the zebrafish s113p53 knockout mutant by deleting one p53-responsive element in its promoter. The s113p53 knockout mutant embryos are more sensitive to γ-irradiation due to accumulating higher level of DNA damage extents and apoptotic cells. The results demonstrated that both of functions of s113p53/s133p53 in antagonizing apoptosis and promoting DNA DSB repair are important for its pro-survival characters. Finally, we demonstrated that s113p53/s133p53 promotes DNA DSB repair through up-regulating the expression of the DNA DSB repair genes rad51, ligaseIV (lig4) and rad52, which is independent of full-length p53. Promoter analysis showed that s113p53 binds to a novel type of p53 RE in the promoters of the three genes. Hence, we revealed that p53 coordinates with its isoform s113p53/s133p53 to protect genomic stability upon ionizing irradiation: at the early stage after irradiation, full-length p53 is quickly accumulated to a high level in cells harboring severe DNA damage to inhibit DNA DSB repair and to guide such cells to undergo apoptosis, whereas p53 protein is accumulated to a relative low level in cells with less and fixable DNA damage, thus to activate the transcription of its target genes including mdm2 and s113p53/s133p53. The expression of mdm2 promotes p53 protein degradation, but not s113p53/s133p53 because s113p53/s133p53 lacks the mdm2-interacting motif. Therefore, at the later stage, s113p53/s133p53 protein can accumulate to higher levels in cells with less DNA damage as p53 protein decreases to the basal level. The accumulation of s113p53 not only protects cells from death by its anti-apoptotic function but also ensures genetic stability by promoting DNA DSB repair.

The DNA-binding and Transcription-Activation Abilities of P53 Are Necessary but Not Sufficient for Its Antiproliferation Function.

Arginine Methylation of Hnrnp K Enhances P53 Transcriptional Activity.

Inhibition of Nonsense-Mediated Decay Rescues P53β/γ Isoform Expression and Activates the P53 Pathway in MDM2-overexpressing and Select P53-Mutant Cancers

P53 Transcriptional Activity is Essential for P53-Dependent Apoptosis Following DNA Damage

Abstract SY02-02: Tumor Suppression in the Absence of P53-Mediated Cell Cycle Arrest, Apoptosis, and Senescence.

Transcription activity is required for p53-dependent tumor suppression

Ser18 and 23 Phosphorylation is Required for P53-Dependent Apoptosis and Tumor Suppression

Modeling the Etiology of p53-mutated Cancer Cells

Novel Roles For P53 In The Genesis And Targeting Of Tetraploid Cancer Cells

Inhibitory Effect of Bcl-2 on P53-Mediated Transactivation Following Genotoxic Stress

Limited role of N-terminal phosphoserine residues in the activation of transcription by p53

Cell Type- and Promoter-specific Roles of Ser18 Phosphorylation in Regulating p53 Responses

The Nuclear Function of P53 is Required for Puma-Mediated Apoptosis Induced by Dna Damage

Δ113p53/Δ133p53: survival and integrity.

DNA-dependent Protein Kinase-independent Activation of p53 in Response to DNA Damage

Tumor Suppressor P53 Can Participate in Transcriptional Induction of the GADD45 Promoter in the Absence of Direct DNA Binding

A Conserved Mechanism for Binding of p53 DNA-Binding Domain and Anti-Apoptotic Bcl-2 Family Proteins

DNA repair processes are critical mediators of p53-dependent tumor suppression

Chromosome Stability, in the Absence of Apoptosis, is Critical for Suppression of Tumorigenesis in Trp53 Mutant Mice

Conformational Stability and Dynamics of the Cancer‐associated Isoform Δ133p53β Are Modulated by P53 Peptides and P53‐specific DNA

Abstract P10: p44, the Amino-terminal Lacking Isoform of p53, is Dispensable for Tumor Suppression but Regulates Male Fertility